The jab uses mRNA technology to train the immune system to fight cancerous cells
Notifications can be managed in browser preferences.
Next article
The jab uses mRNA technology to train the immune system to fight cancerous cells
I would like to be emailed about offers, events and updates from The Independent. Read our Privacy notice
Patients in England with head and neck cancer will be fast-tracked onto a clinical trial for a "potentially transformative" new vaccine, under an initiative announced by the NHS.
Discovery could be ‘significant step’ towards universal cancer vaccine
Researchers found patients with pancreatic cancer and bowel cancer survived more than two years after receiving the vaccine
Researchers say they have developed a novel ‘nanoparticle-based’ jab that can prevent melanoma, pancreatic and triple-negative…
Trials that could prevent the disease from returning are to be expanded over the next year in world-first programme
Until now, patients have had to spend hours on a drip to get the drug pembrolizumab (Keytruda) to treat their cancer.
One early adopter describes how he was in remission ‘within the first two or three weeks’ after the treatment
